Mitsubishi Pharma Europe is the European Headquarters of one of Japan’s largest pharmaceutical companies, Mitsubishi Tanabe Pharma Corporation.

Based in London, Mitsubishi Pharma Europe is engaged in the clinical development of new drugs for the European markets. Mitsubishi Pharma Europe is conducting trials in Europe in the following therapy areas; cardiovascular, diabetes and renal conditions. The staff include regulatory, QA, clinical, biostatistics, medical information, pharmacovigilance, pharmaceutical technology and marketing.

During the summer of 2005, the company saw its first European product launch, argatroban, and this represented a significant landmark for the company as it began commercial operations.